SO
TSVT

STRS Ohio’s 2seventy bio TSVT Stock Holding History

STRS Ohio’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,600
Closed -$23K – 2073
2022
Q3 		$23K Buy
+1,600
New +$23.7K ﹤0.01% 1918

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

STRS Ohio's TSVT Position: Q4 2022 in Review

STRS Ohio sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 1,600 shares — an estimated $23K sold.

STRS Ohio first reported a position in TSVT in Q3 2022 and held it in 1 quarter. The position peaked at $23K in Q3 2022. 141 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • STRS Ohio reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • STRS Ohio sold 1,600 2seventy bio shares in Q4 2022, an estimated $23K.
  • STRS Ohio first reported a position in 2seventy bio in Q3 2022 and held it in 1 quarter.
  • STRS Ohio's 2seventy bio position peaked at $23K in Q3 2022.
  • 141 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.